RNA Interference Therapy Targeting Apolipoprotein C-III in Hypertriglyceridemia
NEJM Evidence · 28.11.2023 · 2 (12)
DOI: 10.1056/evidoa2200325 ↗Kurz gefasst
Fachartikel in der Zeitschrift NEJM Evidence, erschienen am 28.11.2023. Verfasst von Daniel Gaudet und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Université de Montréal and ECOGENE 21 Clinical Research Center, Chicoutimi, Quebec, QC, Canada. Hauptthemen laut MEDLINE: Hypertriglyceridemia. Die Arbeit wurde bisher 70-mal zitiert (Crossref) und nennt 31 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Université de Montréal and ECOGENE 21 Clinical Research Center, Chicoutimi, Quebec, QC, Canada.
- Royal Adelaide Hospital, Adelaide, SA, Australia.
- NSW Health Pathology, Royal Prince Alfred Hospital, Sydney.
- Middlemore Hospital, Auckland, New Zealand.
- Auckland Clinical Studies, Auckland, New Zealand.
- University of the Sunshine Coast, Sippy Downs, QLD, Australia.
Zitieren
APA
Gaudet, D., Clifton, P., Sullivan, D., Baker, J., Schwabe, C., Thackwray, S., Scott, R., Hamilton, J., Given, B., Melquist, S., Zhou, R., Chang, T., San Martin, J., Watts, G. F., Goldberg, I. J., Knowles, J. W., Hegele, R. A., & Ballantyne, C. M. (2023). RNA Interference Therapy Targeting Apolipoprotein C-III in Hypertriglyceridemia. NEJM Evidence, 2(12). https://doi.org/10.1056/evidoa2200325
Vancouver
Gaudet D, Clifton P, Sullivan D, Baker J, Schwabe C, Thackwray S, et al. RNA Interference Therapy Targeting Apolipoprotein C-III in Hypertriglyceridemia. NEJM Evidence. 2023;2(12). doi:10.1056/evidoa2200325
BibTeX
@article{Gaudet2023,
author = {Gaudet, Daniel and Clifton, Peter and Sullivan, David and Baker, John and Schwabe, Christian and Thackwray, Susan and Scott, Russell and Hamilton, James and Given, Bruce and Melquist, Stacey and Zhou, Rong and Chang, Ting and San Martin, Javier and Watts, Gerald F and Goldberg, Ira J and Knowles, Joshua W and Hegele, Robert A and Ballantyne, Christie M},
title = {RNA Interference Therapy Targeting Apolipoprotein C-III in Hypertriglyceridemia},
journal = {NEJM Evidence},
year = {2023},
volume = {2},
number = {12},
doi = {10.1056/evidoa2200325}
}
EUVIMED